The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer

Francesco De Sanctis1, Sara Sandri1, Giovanna Ferrarini1

  • 1Immunology Section, Department of Pathology and Diagnostics, University of Verona , Verona , Italy.

Insights

Reactive nitrogen species (RNS) create a "chemical barrier" impairing anti-tumor immunity. Targeting RNS may offer new strategies for cancer treatment and biomarker discovery.

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • Reactive nitrogen species (RNS) are implicated in immune responses during tumor progression.
  • RNS-dependent post-translational modifications suggest a functional role in immune regulation.
  • These modifications can create a barrier hindering anti-tumor immunity.

Purpose of the Study:

  • To review the immunological and biological roles of RNS-induced modifications in cancer.
  • To explore novel therapeutic strategies targeting RNS in cancer treatment.
  • To identify RNS as potential biomarkers for cancer immunotherapy.

Main Methods:

  • Literature review of RNS in cancer immunology.
  • Analysis of RNS generation pathways (e.g., nitric oxide production, l-arginine catabolism).
  • Discussion of RNS-mediated post-translational modifications of immune factors.

Main Results:

  • RNS modifications impair effector T cell infiltration and function within the tumor microenvironment.
  • Tumor cells and myeloid cells are key sources of RNS during tumor growth.
  • RNS contribute to immune evasion by cancer cells.

Conclusions:

  • RNS play a significant role in modulating the anti-tumor immune response.
  • Targeting RNS presents a promising avenue for improving cancer therapies.
  • Further research into RNS modifications could yield novel cancer biomarkers.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

2.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K